Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | Protein profiling by protein array | |||||||
GSE261672 |
Serum cytokine and chemokine analysis of patients with treatment-naïve unresectable hepatocellular carcinoma and cancer-free chronic liver disease.
|
|
116 | Hikaru Nakahara | Apr 17, 2024 | |||
GSE150859 |
Analysis of DDX39 and DDX56 interacting proteins
|
|
3 | Emil Karaulanov | Mar 11, 2024 | |||
GSE168198 |
Human serum: Control vs. Lung Cancer
|
|
196 | He Yan Bin | Mar 02, 2024 | |||
GSE260475 |
Impaired innate and adaptive immune responses to BNT162b2 SARSCoV-2 vaccination in systemic lupus erythematosus [ACA]
|
|
113 | Allan Feng | Mar 02, 2024 | |||
GSE260478 |
Impaired innate and adaptive immune responses to BNT162b2 SARSCoV-2 vaccination in systemic lupus erythematosus [CTD]
|
|
102 | Allan Feng | Mar 02, 2024 | |||
GSE235074 |
Trypanosoma cruzi conserved proteome microarray
|
|
3 | Eric Dumonteil | Feb 28, 2024 | |||
GSE225341 |
Effekt of recombinant murine Lipocalin-2 (LCN2) on murine macrophages
|
|
10 | Robert Zeiser | Feb 18, 2024 | |||
GSE189986 |
Short-term effects of Elastase inhibition on human islets protein phosphorylation
|
|
24 | Jonathan M Dreyfuss | Feb 13, 2024 | |||
GSE242154 |
Spatial immuno-oncology protein abundance profiles in hepatocellular carcinoma tissues from patients treated with bavituximab and pembrolizumab
|
|
251 | Yujin Hoshida | Feb 08, 2024 | |||
GSE254030 |
Deep phenotyping of Post-infectious Myalgic Encephalomyelitis/Chronic Fatigue Syndrome [Protein plasma]
|
|
42 | Avindra Nath | Jan 24, 2024 | |||
GSE225811 |
Signaling in microglia during CAR Tcell induced Immune cell associated neurotoxicity syndrome (ICANS)
|
|
9 | Robert Zeiser | Jan 23, 2024 | |||
GSE253264 |
MOTS-c peptide binding protein
|
|
1 | Yue Zhai | Jan 18, 2024 | |||
GSE249861 |
Nucleos(t)ide analogs for hepatitis B virus infection differentially regulate the growth factor signaling in hepatocytes
|
|
8 | Masao Honda | Jan 17, 2024 | |||
GSE243657 |
Mucosal and systemic antigen-specific antibody responses correlate with protection against active tuberculosis in nonhuman primates (LAM30 IgM)
|
|
196 | Jacqueline M. Achkar | Jan 10, 2024 | |||
GSE243658 |
Mucosal and systemic antigen-specific antibody responses correlate with protection against active tuberculosis in nonhuman primates (LAM63 IgA)
|
|
270 | Jacqueline M. Achkar | Jan 10, 2024 | |||
GSE243659 |
Mucosal and systemic antigen-specific antibody responses correlate with protection against active tuberculosis in nonhuman primates (LAM63 IgG)
|
|
270 | Jacqueline M. Achkar | Jan 10, 2024 | |||
GSE243663 |
Mucosal and systemic antigen-specific antibody responses correlate with protection against active tuberculosis in nonhuman primates
|
|
1258 | Jacqueline M. Achkar | Jan 10, 2024 | |||
GSE252919 |
FLUAV RAM-IGIP: A modified live influenza virus vaccine that enhances humoral and mucosal responses against influenza. Vaccine Encoding the IgA-Inducing Protein
|
|
112 | Daniel Roberto Perez | Jan 10, 2024 | |||
GSE199141 |
Proteomic characteristics of mesenchymal subtypes of hepatocellular carcinoma
|
|
113 | Ju-Seog Lee | Jan 01, 2024 | |||
GSE231798 |
Loss of B cell Tolerance is TCR Dependent [IgG CTD array]
|
|
91 | Elliot Akama-Garren | Dec 29, 2023 |